Cytosorbents Corp.
$5.76
$0.03 (+0.52%)
$5.75Day Range$5.96
Key Statistics
Market Cap
$18.06M
Shares Outstanding
3.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 17, 2005
Round Lot
100
Locale
US
Trading Data
Day Open
$5.96
Day High
$5.96
Day Low
$5.75
Volume
3.1K
VWAP
$5.88
Prev Close
$5.73
Transactions
--
Acc. Volume
--
About Cytosorbents Corp.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841129 employees305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540973-329-8885IPO May 17, 2005US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001175151
- Composite FIGI
- BBG000C3P8V0
- Share Class FIGI
- BBG001SL7YQ0
- Ticker Root
- CTSO
- SIC Code
- 3841
About Cytosorbents Corp. (CTSO) Stock
Cytosorbents Corp. (CTSO) closed the 2026-09-17 session at $5.76, up 0.52% versus the previous close (+0.03). The stock opened at $5.96 and traded between $5.75 and $5.96 during that session. Session trading volume was 3K shares. The volume-weighted average price (VWAP) is $5.88.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
Cytosorbents Corp. has a market capitalization of $18.1 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. CTSO is listed on the XNAS exchange. The company employs approximately 129 people. Cytosorbents Corp. is headquartered in PRINCETON, NJ. The recorded listing date is 2005-05-17.
On this page you can find market CTSO stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.